UMass Medical University researchers to assess treatment solutions for early COVID-19 infection

UMass Medical University researchers to assess treatment solutions for early COVID-19 infection

UMass Medical College is collaborating in the ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies Demo, which is becoming led by the AIDS Medical Trials Team (ACTG). ACTIV-2 features the two Stage II and Phase III evaluations of investigational brokers for treating early COVID-19. To qualify for ACTIV-2, individuals need to have analyzed positive for SARS-CoV-2 […]

Continue Reading
After a year of pandemic-delayed medical solutions, health professionals are observing far more cases of superior ailments.

After a year of pandemic-delayed medical solutions, health professionals are observing far more cases of superior ailments.

Two clients, both equally of whom endured increased heart damage by delaying care, offered what came to be regular responses. One explained he was fearful of contracting covid-19, the condition caused by the coronavirus, by heading to the healthcare facility. The other affected person went to the emergency room in the early morning, remaining just […]

Continue Reading